Clinical Management of Portal Hypertensive Complications: Hepatic Encephalopathy and Renal Failure

Nov 10 2025
Convention Center: Room 202, Level 2
8:00 AM - 9:30 AM

World Class Speakers

Rakhi Maiwall, MD, DM
Abstract Presenter

Rakhi Maiwall, MD, DM

Institute of Liver and Biliary Sciences
Scott Biggins, MD, MAS, FAASLD
Moderator

Scott Biggins, MD, MAS, FAASLD

University of Pittsburgh
LD
Moderator

Lorna Dove, MD, MPH

Columbia University Medical Center

Description

This abstract session will present the latest research on complications of portal hypertension, including hepatic encephalopathy, ascites, and HRS-AKI. Authors will present novel findings and innovative approaches in diagnosing and managing these conditions, which are pivotal challenges in patients with advanced liver disease.

Journey Maps

Presentations

8:00 AM - 8:15 AM
Aug 06 2026
Convention Center - Room 202, Level 2

Outcomes of Endoscopic Ultrasound-Guided Shunt Modulation for Recurrent Hepatic Encephalopathy: Pushing Boundries of Endohepatology

Rakhi Maiwall, MD, DM , Abstract Presenter
Cirrhosis and Portal Hypertension
8:15 AM - 8:30 AM
Aug 06 2026
Convention Center - Room 202, Level 2

Stent diameter and medications are not associated with reduced odds of hepatic encephalopathy after TIPS: A contemporary multicenter cohort study from the ALTA study group

Rakhi Maiwall, MD, DM , Abstract Presenter
Cirrhosis and Portal Hypertension
8:30 AM - 8:45 AM
Aug 06 2026
Convention Center - Room 202, Level 2

Beacon: At-Home, Self-Administration of a Test for Critical Flicker Frequency as a Screening Test for Minimal Hepatic Encephalopathy

Rakhi Maiwall, MD, DM , Abstract Presenter
Cirrhosis and Portal Hypertension
8:45 AM - 9:00 AM
Aug 06 2026
Convention Center - Room 202, Level 2

Differential effects of vasopressin and terlipressin as adjunct vasopressors on hemodynamic parameters in patients with cirrhosis and septic shock: Final results from the VITEL-C randomized controlled trial [NCT05315557] 

Rakhi Maiwall, MD, DM , Abstract Presenter
Cirrhosis and Portal Hypertension

Objectives

  • Discuss the effects of TIPS placement on hepatic encephalopathy
  • Describe the algorithm for management of HRS-AKI